CeraMax now available in the U.S. for soybean growers


U.S. soybean growers now have a new EPA-registered seed treatment option for guarding soybean crops from sudden death syndrome (SDS) and improving their yields. 

CeraMax is available in the U.S. for the first time through Direct Enterprises, Inc. (DEI), an Indiana-based seed treatment expert.

Containing the active ingredient natamycin, CeraMax empowers the genetic potential of soybean seeds to increase early season vigour for a stronger, more uniform emergence and maximum yield potential according to research findings.
Bill Haubner, DEI co-founder and president, says DEI sought to bring the product to the U.S. after seeing yield trials. “CeraMax is the tool today’s soybean producers need in the war against Fusarium, the fungal disease causing SDS.”
Across research trials in 10 states, where CeraMax was added to Acceleron Standard seed treatments, beans showed significantly lower SDS disease incidence and an average yield increase of 4.3 bushel per acre. “More than 50 field trials were accomplished and compared with an Acceleron-only control treatment,” notes Haubner. “CeraMax also bested hard chemical alternatives ILEVO and Saltro in plant vigour tests with no signs of phytotoxic stress on the beans.”
The company expects to place 20,000 units of the new CeraMax biological in a variety of growing conditions throughout soybean producing areas hardest hit by SDS in recent years.
CeraMax was discovered and is produced by Ceradis, a spin-off of Wageningen University & Research in The Netherlands.


New AG International November/December 2020


Check out our new digital publication in Spanish HERE!

cover 199x282